Asset Acquisitions - Assumptions to Value Warrants (Details) - Emerald Health Therapeutics Inc - EHT Warrants |
Nov. 10, 2022 |
---|---|
Dividend yield | |
Asset Acquisition [Line Items] | |
Warrants and rights outstanding measurement input | 0.0000 |
Volatility | Minimum | |
Asset Acquisition [Line Items] | |
Warrants and rights outstanding measurement input | 1.029 |
Volatility | Maximum | |
Asset Acquisition [Line Items] | |
Warrants and rights outstanding measurement input | 1.146 |
Risk-free interest rate | Minimum | |
Asset Acquisition [Line Items] | |
Warrants and rights outstanding measurement input | 0.0429 |
Risk-free interest rate | Maximum | |
Asset Acquisition [Line Items] | |
Warrants and rights outstanding measurement input | 0.0453 |
Expected term (years) | Minimum | |
Asset Acquisition [Line Items] | |
Expected term (years) | 6 months 21 days |
Expected term (years) | Maximum | |
Asset Acquisition [Line Items] | |
Expected term (years) | 2 years 3 months 7 days |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|